The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural Mesothelioma

Amivantamab Shows Preclinical Immune-Mediated Activity in Mesothelioma Through Dual EGFR and MET Targeting

July 15, 2026

New Mesothelioma Treatment Recommendations Released in 2026: What Patients and Families Should Know

July 21, 2026